UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

UCLA Radiology | Back to Home

Hereditary Hemorrhagic Telangiectasia (HHT)

Print
Email
Share

Hereditary Hemorrhagic Telangiectasia (HHT) Treatment Program

As one of the top ranked health care centers in the United States, at UCLA we constantly strive to combine innovation and clinical care to offer patients the most advanced, patient-centered care in the world. The HHT Center of Excellence at UCLA is a multidisciplinary practice which facilitates the comprehensive coordination of care necessary for treating patients with HHT. Our Mission » | About HHT »

How does HHT affect children?

Link to patient story

Most children with HHT have normal, healthy childhoods, with or without nosebleeds.

View FAQs & Patient Story »

What is HHT?

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant vascular disorder, affecting approximately 1 in 5000 persons. It is an "equal opportunity disorder"; all ethnicities and both genders are similarly affected.
Learn more about HHT »

I Might Have HHT, What should I do?

I think I (or my family member) might have HHT, but I'm not sure. What should I do? Start with a phone call to the HHT center. If there is a chance you might have HHT, a clinic visit can be arranged.
Contact Us »
 

Specific Complications

•  Nosebleeds
•  Pulmonary AVMs
•  Cerebral AVMs

•  Gastrointestinal Bleeding
•  Hepatic AVMs
UCLA Rated One of the Top Hospitals in the Nation